$7.44
Live
Insights on Profound Medical Corp
Revenue is down for the last 2 quarters, 2.06M → 1.91M (in $), with an average decrease of 7.5% per quarter
Netprofit is up for the last 2 quarters, -9.15M → -6.19M (in $), with an average increase of 47.7% per quarter
In the last 1 year, Boston Scientific Corp. has given 45.7% return, outperforming this stock by 90.1%
In the last 3 years, Boston Scientific Corp. has given 79.6% return, outperforming this stock by 137.1%
0.54%
Downside
Day's Volatility :2.63%
Upside
2.11%
4.44%
Downside
52 Weeks Volatility :54.1%
Upside
51.97%
Period | Profound Medical Corp | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -18.76% | -1.0% | 0.0% |
6 Months | -29.92% | 9.6% | 0.0% |
1 Year | -45.46% | 11.0% | 0.0% |
3 Years | -57.53% | 18.5% | -22.6% |
Market Capitalization | 180.0M |
Book Value | $1.88 |
Earnings Per Share (EPS) | -1.29 |
Wall Street Target Price | 12.61 |
Profit Margin | 0.0% |
Operating Margin TTM | -391.73% |
Return On Assets TTM | -30.83% |
Return On Equity TTM | -59.26% |
Revenue TTM | 7.2M |
Revenue Per Share TTM | 0.33 |
Quarterly Revenue Growth YOY | 2.7% |
Gross Profit TTM | 3.0M |
EBITDA | -28.5M |
Diluted Eps TTM | -1.29 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.19 |
EPS Estimate Next Year | -0.98 |
EPS Estimate Current Quarter | -0.3 |
EPS Estimate Next Quarter | -0.28 |
What analysts predicted
Upside of 69.49%
Sell
Neutral
Buy
Profound Medical Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Profound Medical Corp | 0.47% | -29.92% | -45.46% | -57.53% | -24.6% |
Stryker Corporation | 4.27% | 16.65% | 22.1% | 34.77% | 82.03% |
Boston Scientific Corp. | 4.07% | 37.85% | 46.89% | 79.63% | 93.34% |
Edwards Lifesciences Corp. | 3.26% | 27.0% | 2.23% | -8.36% | 51.45% |
Abbott Laboratories | -2.62% | -2.21% | -0.86% | -5.87% | 32.8% |
Medtronic Plc | 0.44% | 2.96% | -1.92% | -33.69% | -13.02% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Profound Medical Corp | NA | NA | NA | -1.19 | -0.59 | -0.31 | NA | 1.88 |
Stryker Corporation | 38.89 | 38.89 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.5 | 63.5 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 37.45 | 37.45 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 31.83 | 31.83 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 29.48 | 29.48 | 1.52 | 5.2 | 0.07 | 0.04 | 0.03 | 38.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Profound Medical Corp | Buy | $180.0M | -24.6% | NA | 0.0% |
Stryker Corporation | Buy | $129.9B | 82.03% | 38.89 | 16.03% |
Boston Scientific Corp. | Buy | $111.1B | 93.34% | 63.5 | 12.05% |
Edwards Lifesciences Corp. | Buy | $52.4B | 51.45% | 37.45 | 23.01% |
Abbott Laboratories | Buy | $177.8B | 32.8% | 31.83 | 13.96% |
Medtronic Plc | Buy | $106.7B | -13.02% | 29.48 | 11.36% |
Gagnon Securities LLC
Fidelity International Ltd
Letko, Brosseau & Associates Inc.
Gagnon Advisors, LLC
AIGH Capital Management, LLC
Raymond James Finl Svs Advisors, Inc.
an inside out approach to prostate ablation profound medical is a canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. profound’s novel technology combines real-time mr imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. it provides a highly precise treatment tailored to patient-specific anatomy and pathology. this method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. the potential of this technology is currently being demonstrated in clinical trials. for more information, visit profoundmedical.com
Organization | Profound Medical Corp |
Employees | 131 |
CEO | Dr. Arun Swarup Menawat MBA, Ph.D. |
Industry | Health Technology |
A Spac I Acquisition Corp
$7.44
-0.13%
Keyarch Acquisition Corp
$7.44
-0.13%
Connexa Sports Technologies Inc
$7.44
-0.13%
Us Value Etf
$7.44
-0.13%
First Wave Biopharma Inc
$7.44
-0.13%
Global X Msci Next Emerging
$7.44
-0.13%
Fat Projects Acquisition Corp
$7.44
-0.13%
Goal Acquisitions Corp
$7.44
-0.13%
Capital Link Global Fintech
$7.44
-0.13%